NO20030233D0 - Process for finding compounds suitable for the treatment and / or prophylaxis of obesity - Google Patents

Process for finding compounds suitable for the treatment and / or prophylaxis of obesity

Info

Publication number: NO20030233D0
Authority: NO; Norway
Prior art keywords: prophylaxis; obesity; treatment; compounds suitable; finding compounds
Prior art date: 2000-07-20

Application number

NO20030233A

Other languages

Norwegian (no)

Other versions

NO20030233L (en

Inventor

Johannes Hebebrand

Jochen Antel

Ulf Preuschoff

Samuel David

Holger Sann

Michael Weske

Original Assignee

Solvay Pharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-20

Filing date

2003-01-17

Publication date

2003-01-17

2003-01-17 Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh

2003-01-17 Publication of NO20030233D0 publication Critical patent/NO20030233D0/en

2003-03-19 Publication of NO20030233L publication Critical patent/NO20030233L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Wood Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Immunology (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

NO20030233A 2000-07-20 2003-01-17 Process for finding compounds suitable for the treatment and / or prophylaxis of obesity NO20030233L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10035227A DE10035227A1 (en)	2000-07-20	2000-07-20	Selection and use of lipogenesis inhibitors for the treatment and prevention of obesity
PCT/EP2001/008051 WO2002007821A1 (en)	2000-07-20	2001-07-12	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Publications (2)

Publication Number	Publication Date
NO20030233D0 true NO20030233D0 (en)	2003-01-17
NO20030233L NO20030233L (en)	2003-03-19

Family

ID=7649538

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030233A NO20030233L (en)	2000-07-20	2003-01-17	Process for finding compounds suitable for the treatment and / or prophylaxis of obesity

Country Status (27)

Country	Link
EP (1)	EP1307262B1 (en)
JP (1)	JP2004504053A (en)
KR (1)	KR100818827B1 (en)
CN (1)	CN1443085B (en)
AR (1)	AR028730A1 (en)
AT (1)	ATE278441T1 (en)
AU (2)	AU7753401A (en)
BR (1)	BR0112547A (en)
CA (1)	CA2416647A1 (en)
CZ (1)	CZ2003156A3 (en)
DE (2)	DE10035227A1 (en)
DZ (1)	DZ3393A1 (en)
ES (1)	ES2230346T3 (en)
HK (1)	HK1057499A1 (en)
HU (1)	HUP0302309A3 (en)
IL (2)	IL153971A0 (en)
MX (1)	MXPA02012907A (en)
NO (1)	NO20030233L (en)
NZ (1)	NZ523960A (en)
PL (1)	PL201165B1 (en)
PT (1)	PT1307262E (en)
RU (1)	RU2268721C2 (en)
SK (1)	SK287607B6 (en)
TR (1)	TR200402670T4 (en)
TW (1)	TWI274157B (en)
UA (1)	UA74588C2 (en)
WO (1)	WO2002007821A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007538054A (en)	2004-05-19	2007-12-27	ゾルファイ　ファーマスーティカルズ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング	Drug containing N-sulfamoyl-N'-arylpiperazine for the prevention or treatment of obesity and related diseases
MY147767A (en)	2004-06-16	2013-01-31	Janssen Pharmaceutica Nv	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AU2006249577A1 (en)	2005-05-20	2006-11-30	Janssen Pharmaceutica N.V.	Process for preparation of sulfamide derivatives
TW200804393A (en)	2005-11-14	2008-01-16	Solvay Pharm Gmbh	Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use
US8937096B2 (en)	2005-12-19	2015-01-20	Janssen Pharmaceutica Nv	Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8492431B2 (en)	2005-12-19	2013-07-23	Janssen Pharmaceutica, N.V.	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8716231B2 (en)	2005-12-19	2014-05-06	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en)	2005-12-19	2014-04-08	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en)	2005-12-19	2013-07-30	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
WO2007137167A2 (en)	2006-05-19	2007-11-29	Janssen Pharmaceutica N.V.	Co-therapy for the treatment of epilepsy
US8455432B2 (en)	2007-01-25	2013-06-04	Verva Pharmaceuticals Ltd.	Insulin sensitisers and methods of treatment
EA018567B1 (en)	2008-06-23	2013-08-30	Янссен Фармацевтика Нв	Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)sulfamide
US8815939B2 (en)	2008-07-22	2014-08-26	Janssen Pharmaceutica Nv	Substituted sulfamide derivatives
CN104487073A (en) *	2012-05-24	2015-04-01	维尔瓦制药有限公司	A method of improving liver function
CN106770611B (en) *	2016-12-22	2019-01-29	广西师范大学	A method of entering mitochondria for cell in-situ detection small molecule compound
RU2771430C1 (en) *	2021-09-21	2022-05-04	Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН)	Method for the quantitative determination of anticonvulsants in the blood plasma of patients with epilepsy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4552897A (en) *	1983-02-01	1985-11-12	American Cyanamid Company	Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) *	1987-09-04	2001-09-11	Beecham Group P.L.C.	Compounds
US5126324A (en) *	1990-06-07	1992-06-30	Genentech, Inc.	Method of enhancing growth in patients using combination therapy
MD1486G2 (en) *	1992-10-29	2001-11-30	Genentech, Inc.	Method for treatment or prevention of obesity
AU693478B2 (en) *	1994-11-10	1998-07-02	Metabolic Pharmaceuticals Limited	Treatment of obesity
HU226775B1 (en) *	1996-06-28	2009-09-28	Ortho Mcneil Pharm Inc	The use of topiramate and its derivatives for preparation of pharmaceutical compositions useful for treating obesity or for weight loss
US20030100594A1 (en) *	2001-08-10	2003-05-29	Pharmacia Corporation	Carbonic anhydrase inhibitor

2000
- 2000-07-20 DE DE10035227A patent/DE10035227A1/en not_active Withdrawn
2001
- 2001-06-15 AR ARP010102883A patent/AR028730A1/en unknown
- 2001-07-12 WO PCT/EP2001/008051 patent/WO2002007821A1/en active IP Right Grant
- 2001-07-12 TR TR2004/02670T patent/TR200402670T4/en unknown
- 2001-07-12 RU RU2003104803/14A patent/RU2268721C2/en not_active IP Right Cessation
- 2001-07-12 PL PL363518A patent/PL201165B1/en not_active IP Right Cessation
- 2001-07-12 BR BR0112547-8A patent/BR0112547A/en not_active Application Discontinuation
- 2001-07-12 JP JP2002513551A patent/JP2004504053A/en active Pending
- 2001-07-12 MX MXPA02012907A patent/MXPA02012907A/en active IP Right Grant
- 2001-07-12 NZ NZ52396001A patent/NZ523960A/en not_active IP Right Cessation
- 2001-07-12 IL IL15397101A patent/IL153971A0/en unknown
- 2001-07-12 CN CN018129730A patent/CN1443085B/en not_active Expired - Fee Related
- 2001-07-12 CZ CZ2003156A patent/CZ2003156A3/en unknown
- 2001-07-12 AU AU7753401A patent/AU7753401A/en active Pending
- 2001-07-12 SK SK61-2003A patent/SK287607B6/en not_active IP Right Cessation
- 2001-07-12 HU HU0302309A patent/HUP0302309A3/en unknown
- 2001-07-12 KR KR1020037000620A patent/KR100818827B1/en not_active Expired - Fee Related
- 2001-07-12 CA CA002416647A patent/CA2416647A1/en not_active Abandoned
- 2001-07-12 DZ DZ013393A patent/DZ3393A1/en active
- 2001-07-12 AT AT01955345T patent/ATE278441T1/en active
- 2001-07-12 EP EP01955345A patent/EP1307262B1/en not_active Expired - Lifetime
- 2001-07-12 ES ES01955345T patent/ES2230346T3/en not_active Expired - Lifetime
- 2001-07-12 DE DE50104023T patent/DE50104023D1/en not_active Expired - Lifetime
- 2001-07-12 AU AU2001277534A patent/AU2001277534B9/en not_active Ceased
- 2001-07-12 PT PT01955345T patent/PT1307262E/en unknown
- 2001-07-16 TW TW090117382A patent/TWI274157B/en not_active IP Right Cessation
- 2001-12-07 UA UA2003021453A patent/UA74588C2/en unknown
2003
- 2003-01-15 IL IL153971A patent/IL153971A/en not_active IP Right Cessation
- 2003-01-17 NO NO20030233A patent/NO20030233L/en unknown
2004
- 2004-01-15 HK HK04100307.4A patent/HK1057499A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
MXPA02012907A (en)	2003-09-22
HUP0302309A2 (en)	2003-11-28
DE50104023D1 (en)	2004-11-11
TR200402670T4 (en)	2004-11-22
ATE278441T1 (en)	2004-10-15
NO20030233L (en)	2003-03-19
DZ3393A1 (en)	2002-01-31
PL363518A1 (en)	2004-11-29
AU7753401A (en)	2002-02-05
SK612003A3 (en)	2003-06-03
TWI274157B (en)	2007-02-21
JP2004504053A (en)	2004-02-12
SK287607B6 (en)	2011-03-04
CA2416647A1 (en)	2003-01-20
UA74588C2 (en)	2006-01-16
PT1307262E (en)	2004-12-31
CN1443085A (en)	2003-09-17
PL201165B1 (en)	2009-03-31
RU2268721C2 (en)	2006-01-27
KR20030022284A (en)	2003-03-15
AU2001277534B2 (en)	2005-09-29
CZ2003156A3 (en)	2003-06-18
HUP0302309A3 (en)	2005-06-28
IL153971A (en)	2009-07-20
HK1057499A1 (en)	2004-04-08
EP1307262A1 (en)	2003-05-07
KR100818827B1 (en)	2008-04-01
AU2001277534B9 (en)	2006-02-23
EP1307262B1 (en)	2004-10-06
BR0112547A (en)	2003-07-01
NZ523960A (en)	2004-12-24
DE10035227A1 (en)	2002-01-31
WO2002007821A1 (en)	2002-01-31
AR028730A1 (en)	2003-05-21
IL153971A0 (en)	2003-07-31
CN1443085B (en)	2010-04-28
ES2230346T3 (en)	2005-05-01

Publication	Publication Date	Title
NO20030233D0 (en)	2003-01-17	Process for finding compounds suitable for the treatment and / or prophylaxis of obesity
NO20054369D0 (en)	2005-09-21	Use of an IBAT inhibitor for the treatment and prophylaxis of constipation
NO20013380D0 (en)	2001-07-06	2-aminobenzoxazinone derivatives for the treatment of obesity
NO20013381D0 (en)	2001-07-06	2-oxybenzoxazinone derivatives for the treatment of obesity
NO20041216L (en)	2004-05-05	Imidazole-4-carboxamide derivatives, preparation and use thereof for the treatment of obesity
NO20020770L (en)	2002-04-16	Use of monoamine oxidase inhibitors for the manufacture of drugs suitable for the treatment of obesity
HK1062518A1 (en)	2004-11-12	Materials and methods for the treatment or prevention of obesity
AU2001271567A1 (en)	2002-01-14	Use of geldanamycin and related compounds for prophylaxis or treatment of fibrogenic disorders
SI1231920T1 (en)	2007-06-30	Use of epinastin for the treatment of allergic rhinitis/conjunctivitis
NO20044195L (en)	2004-10-01	Biophosphonic acids for the treatment and prevention of osteoporosis
NO20052476D0 (en)	2005-05-23	2-alkyl (2-amino-3-aryl-propionyl) -piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity.
GB2418025B (en)	2006-09-20	Device for the prevention or treatment of ulcers
IS6917A (en)	2003-08-18	Epothilone derivatives for the treatment of difficult tumors
DK1455794T3 (en)	2011-03-14	CIC-2 channel opener for the treatment of gastric or intestinal ulcer
NO20023482D0 (en)	2002-07-22	Procedure for the treatment of substance abuse
AU2003263760A1 (en)	2004-01-19	Methods for the treatment or prevention of obesity
NO20033498L (en)	2003-08-07	Process for the treatment and drying of wood
AU2001277534A1 (en)	2002-05-02	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
AU2002364171A8 (en)	2003-06-30	Materials and methods for the treatment or prevention of obesity
PT1412343E (en)	2006-12-29	Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
SI1562577T1 (en)	2012-01-31	Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by thalidomide
ZA200501288B (en)	2005-09-05	Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2001239301A1 (en)	2001-10-08	Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression
AU2000272704A1 (en)	2002-03-26	Use of compounds for the treatment of obesity
AU2002251202A1 (en)	2002-10-15	Intimins for the prevention or treatment of infections: i